| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044069571 |
| P356 | DOI | 10.1186/S13075-014-0479-Z |
| P932 | PMC publication ID | 4245785 |
| P698 | PubMed publication ID | 25394473 |
| P5875 | ResearchGate publication ID | 268283087 |
| P50 | author | Alberto Mantovani | Q22069468 |
| Barbara Bottazzi | Q42306567 | ||
| Marta Greco | Q57167148 | ||
| Enrico Tombetti | Q57167153 | ||
| Patrizia Rovere-Querini | Q62579985 | ||
| P2093 | author name string | Alessandro Del Maschio | |
| Francesco De Cobelli | |||
| Angelo A Manfredi | |||
| Elena Baldissera | |||
| Maria Grazia Sabbadini | |||
| Maurizio Papa | |||
| Annalaura Salerno | |||
| Silvia Sartorelli | |||
| Enrica Paola Bozzolo | |||
| Maria Chiara Di Chio | |||
| P2860 | cites work | Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension | Q33698036 |
| Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis | Q33748025 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis | Q34019382 | ||
| An integrated view of humoral innate immunity: pentraxins as a paradigm | Q34020449 | ||
| PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation | Q34106947 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors | Q34323215 | ||
| Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. | Q34324823 | ||
| Anti-cytokine treatment for Takayasu arteritis: State of the art | Q34377764 | ||
| Coronary in-stent restenosis: current status and future strategies. | Q34491418 | ||
| Immune mechanisms in medium and large-vessel vasculitis | Q34777943 | ||
| Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases | Q36830914 | ||
| Takayasu arteritis: what is the long-term prognosis? | Q37013683 | ||
| Pentraxins, humoral innate immunity and tissue injury | Q37200012 | ||
| Takayasu arteritis--advances in diagnosis and management | Q37769408 | ||
| The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling | Q37851153 | ||
| Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts | Q37881136 | ||
| The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules | Q38092832 | ||
| Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients | Q38880094 | ||
| Takayasu arteritis | Q43829353 | ||
| Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo | Q43905775 | ||
| Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center. | Q43962455 | ||
| Pentraxin-3 as a marker of disease activity in Takayasu arteritis | Q45208023 | ||
| Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? | Q46067926 | ||
| Angiographic findings of Takayasu arteritis: new classification. | Q47784114 | ||
| Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production. | Q50865174 | ||
| Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease. | Q51266681 | ||
| Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). | Q53348490 | ||
| Interleukin 6 targeting in refractory Takayasu arteritis: serial noninvasive imaging is mandatory to monitor efficacy. | Q54507708 | ||
| Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques. | Q54595226 | ||
| Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: Relevance for recent optic nerve ischemia | Q56942323 | ||
| Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
| EXPRESSION OF MONOCYTE CHEMOTACTIC PROTEIN-3 IN HUMAN MONOCYTES EXPOSED TO THE MYCOBACTERIAL CELL WALL COMPONENT LIPOARABINOMANNAN | Q56943401 | ||
| Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment | Q74455251 | ||
| Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients | Q79844585 | ||
| Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis | Q82691213 | ||
| Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity | Q83493737 | ||
| Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker | Q83863005 | ||
| Diagnosis and assessment of Takayasu arteritis by multiple biomarkers | Q85276189 | ||
| Outcomes of patients with takayasu arteritis treated with infliximab | Q86640183 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P304 | page(s) | 479 | |
| P577 | publication date | 2014-11-14 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis | |
| P478 | volume | 16 |
| Q38970688 | 18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis |
| Q36287340 | Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis |
| Q64880684 | Biomarkers in Vasculitides of the Nervous System. |
| Q37182250 | Chromogranin-A production and fragmentation in patients with Takayasu arteritis |
| Q33568763 | Clinical study of children with Takayasu arteritis: a retrospective study from a single center in China |
| Q26765359 | Diagnostic approach and current treatment options in childhood vasculitis |
| Q26744644 | Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases |
| Q35782029 | High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins |
| Q89687402 | Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis? |
| Q36538797 | Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study |
| Q39160620 | Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis. |
| Q38367777 | New insights on biomarkers in systemic vasculitis |
| Q26782601 | Outcome assessment in Takayasu arteritis |
| Q64971884 | PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases. |
| Q50533824 | Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies. |
| Q48663407 | Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus |
| Q40459457 | Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience. |
| Q39632598 | Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients |
| Q35354592 | Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. |
| Q37604058 | The clearance of cell remnants and the regeneration of the injured muscle depend on soluble pattern recognition receptor PTX3. |
| Q48193738 | The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis |
| Q26749091 | Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis |
Search more.